HK1071312A1 - Diclofenac- based composition for the topical tre atment of oropharyngeal cavity disorders - Google Patents

Diclofenac- based composition for the topical tre atment of oropharyngeal cavity disorders

Info

Publication number
HK1071312A1
HK1071312A1 HK05104340A HK05104340A HK1071312A1 HK 1071312 A1 HK1071312 A1 HK 1071312A1 HK 05104340 A HK05104340 A HK 05104340A HK 05104340 A HK05104340 A HK 05104340A HK 1071312 A1 HK1071312 A1 HK 1071312A1
Authority
HK
Hong Kong
Prior art keywords
diclofenac
topical
based composition
oropharyngeal cavity
cavity disorders
Prior art date
Application number
HK05104340A
Other languages
English (en)
Inventor
Mario Pinza
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Publication of HK1071312A1 publication Critical patent/HK1071312A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
HK05104340A 2002-05-10 2005-05-24 Diclofenac- based composition for the topical tre atment of oropharyngeal cavity disorders HK1071312A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2002MI000986A ITMI20020986A1 (it) 2002-05-10 2002-05-10 Composizione a base di diclofenac per il trattamento topico di affezioni del cavo orofaringeo
PCT/EP2003/004044 WO2003094905A1 (fr) 2002-05-10 2003-04-16 Composition a base de diclofenac pour traitement local de troubles de cavite oropharyngee

Publications (1)

Publication Number Publication Date
HK1071312A1 true HK1071312A1 (en) 2005-07-15

Family

ID=11449862

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05104340A HK1071312A1 (en) 2002-05-10 2005-05-24 Diclofenac- based composition for the topical tre atment of oropharyngeal cavity disorders

Country Status (22)

Country Link
US (1) US20050100597A1 (fr)
EP (1) EP1503747B1 (fr)
JP (1) JP2005526120A (fr)
KR (1) KR20040111415A (fr)
CN (1) CN1303992C (fr)
AR (1) AR039977A1 (fr)
AT (1) ATE333872T1 (fr)
AU (1) AU2003232480B2 (fr)
CA (1) CA2477773C (fr)
DE (1) DE60307086T2 (fr)
DK (1) DK1503747T3 (fr)
EA (1) EA006165B1 (fr)
ES (1) ES2268402T3 (fr)
GE (1) GEP20063822B (fr)
HK (1) HK1071312A1 (fr)
IL (2) IL163871A0 (fr)
IT (1) ITMI20020986A1 (fr)
MX (1) MXPA04010401A (fr)
PL (1) PL215221B1 (fr)
PT (1) PT1503747E (fr)
UA (1) UA79110C2 (fr)
WO (1) WO2003094905A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20032523A1 (it) 2003-12-19 2005-06-20 Acraf Forma di dosaggio per uso orale comprendente un farmaco
ITMI20040235A1 (it) * 2004-02-13 2004-05-13 Therapicon Srl Preparazione farmaceutica per il cavo orale
CN101138544B (zh) * 2006-09-06 2010-09-29 上海医药工业研究院 双氯芬酸或其盐局部成膜凝胶组合物及其应用
BRPI0717769A2 (pt) 2006-10-17 2013-11-05 Nuvo Res Formulação de gel, método para o tratamento da osteoartrite em um indivíduo sofrendo de dor articular, e, uso de diclofenac de sódio
US8546450B1 (en) 2009-03-31 2013-10-01 Nuvo Research Inc. Treatment of pain with topical diclofenac compounds
US8618164B2 (en) 2009-03-31 2013-12-31 Nuvo Research Inc. Treatment of pain with topical diclofenac compounds
US20120003162A1 (en) * 2010-06-30 2012-01-05 Mcneil-Ppc, Inc. Methods of Preparing Non-Alcohol Bioactive Esential Oil Mouth Rinses
KR101936192B1 (ko) * 2010-12-29 2019-01-08 엘지전자 주식회사 공기조화기의 실외기
DE102011111944A1 (de) * 2011-08-29 2013-02-28 Richard A. Huthmacher Verwendung von Diclofenac zur Verhinderung und Behandlung grippaler Infekte sowie durch grippale Infekte bewirkter Krankheitssymtome
WO2016001643A1 (fr) * 2014-06-30 2016-01-07 Mitochondrial Substrate Invention Limited Solutions de substances nutritives pour l'amélioration de la fonction cognitive
CN104546527A (zh) * 2014-12-29 2015-04-29 福建省闽东力捷迅药业有限公司 一种含七叶皂苷钠的漱口液及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT370721B (de) * 1981-02-24 1983-04-25 Ciba Geigy Ag Verfahren zur herstellung von neuen salzen der 2- (2,6-dichloranilino)-phenylessigsaeure, der
EP0373103B1 (fr) * 1988-11-10 1993-03-31 Ciba-Geigy Ag Formulation orale liquide
CA1340994C (fr) * 1989-09-21 2000-05-16 Rudolf Edgar Dr. Falk Traitement de maladies et d'etats pathologiques
US5028413A (en) * 1990-03-21 1991-07-02 Bausch & Lomb Incorporated Novel fluoride-containing dentifrice
IT1243342B (it) * 1990-07-13 1994-06-10 Farcon Ag Composizioni farmaceutiche orali liquide ad attivita' antiinfiammatoria
US5972906A (en) * 1991-07-03 1999-10-26 Hyal Pharmaceutical Corporation Treatment of mucous membrane disease, trauma or condition and for the relief of pain thereof
IT1250636B (it) * 1991-07-04 1995-04-21 Ricerche Di Schiena Del Dr Mic Sale del diclofenac, metodo di preparazione e composizioni farmaceutiche che lo contengono.
US5626838A (en) * 1995-03-13 1997-05-06 The Procter & Gamble Company Use of ketorolac for treatment of squamous cell carcinomas of the oral cavity or oropharynx
CN1059797C (zh) * 1995-11-22 2000-12-27 王树力 双氯芬酸钠喷雾剂

Also Published As

Publication number Publication date
CA2477773C (fr) 2011-01-18
EA006165B1 (ru) 2005-10-27
DE60307086D1 (de) 2006-09-07
AU2003232480A1 (en) 2003-11-11
IL163871A (en) 2007-10-31
EA200401090A1 (ru) 2005-02-24
EP1503747A1 (fr) 2005-02-09
ES2268402T3 (es) 2007-03-16
DK1503747T3 (da) 2006-11-27
WO2003094905A1 (fr) 2003-11-20
IL163871A0 (en) 2005-12-18
PT1503747E (pt) 2006-11-30
PL215221B1 (pl) 2013-11-29
MXPA04010401A (es) 2005-02-17
ITMI20020986A0 (it) 2002-05-10
ATE333872T1 (de) 2006-08-15
CA2477773A1 (fr) 2003-11-20
US20050100597A1 (en) 2005-05-12
AU2003232480B2 (en) 2008-07-31
WO2003094905A8 (fr) 2004-04-01
DE60307086T2 (de) 2007-02-01
CN1652763A (zh) 2005-08-10
PL371426A1 (en) 2005-06-13
UA79110C2 (en) 2007-05-25
KR20040111415A (ko) 2004-12-31
EP1503747B1 (fr) 2006-07-26
GEP20063822B (en) 2006-05-10
CN1303992C (zh) 2007-03-14
JP2005526120A (ja) 2005-09-02
ITMI20020986A1 (it) 2003-11-10
AR039977A1 (es) 2005-03-09

Similar Documents

Publication Publication Date Title
HK1071312A1 (en) Diclofenac- based composition for the topical tre atment of oropharyngeal cavity disorders
IL209842A0 (en) Compounds for the treatment of metabolic disorders
IL169332A0 (en) Compounds for the treatment of metabolic disorders
IL173456A0 (en) Process for the preparation of 4-amino-3-quinolinecarbonitriles
SG120960A1 (en) Fabricated repair of cast nozzle
AU2003286728A8 (en) Compounds for the treatment of metabolic disorders
IL175743A0 (en) Process for the preparation of thiazolopyrimidines
HU0103986D0 (en) New compounds with therapeutic effect
EP1389467A4 (fr) Compositions therapeutiques permettant de reparer la chondropathie
PL1691814T3 (pl) Środki przeciwzapalne
AU2003220483A1 (en) Substituted pyrazolyl compounds for the treatment of inflammation
IL165137A0 (en) Process for the preparation of thioalkylamine derivatives
AU2003282510A8 (en) Hexahydro-benzimidazolone compounds useful as anti-inflammatory agents
HK1095145A1 (en) Process for the preparation of n-arylmorpholinones n-
PL371583A1 (en) Process for the preparation of 7alpha-methylsteroids
SG111997A1 (en) Improved process for the preparation of polyalkylphenoxyaminoalkanes
EP1516868A4 (fr) Procede de preparation de dimethylamine
SI1503747T1 (sl) Sestavek na osnovi diklofenaka za topicno zdravljenje motenj orofaringealne votline
IL164788A0 (en) Process for the preparation of 3-isochromanone
HK1087111A1 (en) Process for the preparation of nicotinaldehydes
AU2003239967A1 (en) Compound for the treatment of cns disorders
AU2003286845A8 (en) Amyloid plaque formation by glycosaminoglycans
EP1549327A4 (fr) Composition pour le traitement des hemorroides
PL357664A1 (en) Method of modification of the molecule
HUP0300255A3 (en) Process for the preparation of 2-phenyl-4-methyl-1-tosil-piperazine

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20180416